logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Dawei Ding

chiatai tianqing pharmaceutical group co., ltd
H指数:10
被引数:337

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib in Patients with Myelofibrosis who were Refractory or Relapsed or Intolerant to Ruxolitinib: A Single-Arm, Multicenter, Open-Label, Phase Ib Study

一款首创的JAK/ROCK抑制剂Rovadicitinib，用于对Ruxolitinib耐药或复发或不能耐受的骨髓纤维化患者：一项单臂、多中心、开放标签、 Ib期研究

European Journal of Pharmacology
IF4.7
2025-08-050
PRE
Minghua Hong; Dawei Ding; Min Zhang; Sujun Gao; Luxi Song; Duoer Wu; Shanli Lao; Ding Yu; Chunkang Chang
Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria

原发性胆汁性胆管炎患者肝脏硬度的预后意义: Baveno VII标准的验证

HEPATOLOGY INTERNATIONAL
IF6.1
2023-09-192
OAAI
Ding, Dawei; Guo, Guanya; Cui, Lina; Jia, Gui; Wang, Xiufang; Zhang, Miao; Tian, Siyuan; Zheng, Linhua; Liu, Yansheng; Hu, Yinan; Xuan, Guoyun; Yang, Jiaqi; Yang, Chunmei; Sun, Ruiqing; Deng, Juan; Guo, Changcun; Chen, Yu; Shang, Yulong; Han, Ying

研究方向

暂未获取到该数据
G
Guanya Guo
H 指数:12论文数:48被引数:417
Y
Ying Han
H 指数:46论文数:381被引数:7,129
Y
Yinan Hu
H 指数:22论文数:107被引数:1,677
Y
Yulong Shang
H 指数:23论文数:76被引数:2,336
G
Gui Jia
H 指数:10论文数:75被引数:403
L
Lina Cui
H 指数:28论文数:211被引数:3,668
刘宴升 封面图
刘宴升
H 指数:48论文数:314被引数:1.4万
X
Xiufang Wang
H 指数:26论文数:170被引数:3,283
J
Jiahao Yu
H 指数:11论文数:31被引数:1,033
D
Dandan Sun
H 指数:60论文数:262被引数:1.0万